Brandt L, Campbell A, Jones J, Martinez S, Neale J, Parkin S
Subst Abus. 2021; 43(1):581-591.
PMID: 34520679
PMC: 8810579.
DOI: 10.1080/08897077.2021.1975870.
Dahlem C, Scalera M, Chen B, McCabe S, Boyd C
Subst Abus. 2019; 41(4):485-492.
PMID: 31638875
PMC: 11608094.
DOI: 10.1080/08897077.2019.1671946.
Hargraves D, White C, Mauger M, Puthota A, Pallerla H, Wigle P
Pharm Pract (Granada). 2019; 17(3):1591.
PMID: 31592036
PMC: 6763304.
DOI: 10.18549/PharmPract.2019.3.1591.
Bennett A, Watford J, Elliott L, Wolfson-Stofko B, Guarino H
Addict Behav. 2019; 99:106036.
PMID: 31494452
PMC: 6791780.
DOI: 10.1016/j.addbeh.2019.106036.
Behar E, Chang J, Countess K, Matheson T, Santos G, Coffin P
Subst Use Misuse. 2019; 54(12):1929-1937.
PMID: 31070106
PMC: 7185847.
DOI: 10.1080/10826084.2019.1609988.
Comorbid opioid use is undertreated among forensic patients with schizophrenia.
Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J
Subst Abuse Treat Prev Policy. 2018; 13(1):39.
PMID: 30400965
PMC: 6219173.
DOI: 10.1186/s13011-018-0177-y.
Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.
Heavey S, Delmerico A, Burstein G, Moore C, Wieczorek W, Collins R
J Community Health. 2017; 43(2):304-311.
PMID: 28852906
PMC: 5832501.
DOI: 10.1007/s10900-017-0422-8.
Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.
McAuley A, Bouttell J, Barnsdale L, Mackay D, Lewsey J, Hunter C
Addiction. 2016; 112(2):301-308.
PMID: 27614084
PMC: 5248605.
DOI: 10.1111/add.13602.
Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings.
Deanna Wilson J, Spicyn N, Matson P, Alvanzo A, Feldman L
Subst Abus. 2016; 37(3):480-487.
PMID: 26820604
PMC: 6400459.
DOI: 10.1080/08897077.2016.1142921.
New Perspectives in the Treatment of Opioid-Induced Respiratory Depression.
Fala L, Welz J
Am Health Drug Benefits. 2015; 8(6 Suppl 3):S51-63.
PMID: 26629261
PMC: 4665080.
Flumazenil, naloxone and the 'coma cocktail'.
Sivilotti M
Br J Clin Pharmacol. 2015; 81(3):428-36.
PMID: 26469689
PMC: 4767210.
DOI: 10.1111/bcp.12731.
Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.
Davis C, Carr D, Southwell J, Beletsky L
Am J Public Health. 2015; 105(8):1530-7.
PMID: 26066921
PMC: 4504282.
DOI: 10.2105/AJPH.2015.302638.
A social gradient in fatal opioids and cocaine related overdoses?.
Origer A, le Bihan E, Baumann M
PLoS One. 2015; 10(5):e0125568.
PMID: 25938451
PMC: 4418844.
DOI: 10.1371/journal.pone.0125568.
Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010.
Charlson F, Baxter A, Dua T, Degenhardt L, Whiteford H, Vos T
Epidemiol Psychiatr Sci. 2014; 24(2):121-40.
PMID: 25497332
PMC: 6998140.
DOI: 10.1017/S2045796014000687.
Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study.
Arribas-Ibar E, Sanchez-Niubo A, Majo X, Domingo-Salvany A, Brugal M
Harm Reduct J. 2014; 11(1):33.
PMID: 25416534
PMC: 4247710.
DOI: 10.1186/1477-7517-11-33.
Police officers' and paramedics' experiences with overdose and their knowledge and opinions of Washington State's drug overdose-naloxone-Good Samaritan law.
Banta-Green C, Beletsky L, Schoeppe J, Coffin P, Kuszler P
J Urban Health. 2013; 90(6):1102-11.
PMID: 23900788
PMC: 3853169.
DOI: 10.1007/s11524-013-9814-y.
Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF/OIF veterans in New York City.
Bennett A, Elliott L, Golub A
Subst Use Misuse. 2013; 48(10):894-907.
PMID: 23869461
PMC: 3789237.
DOI: 10.3109/10826084.2013.796991.
Efforts to reduce overdose deaths.
Sherman S, Han J, Welsh C, Chaulk P, Serio-Chapman C
Am J Public Health. 2013; 103(8):e1-2.
PMID: 23763429
PMC: 4007886.
DOI: 10.2105/AJPH.2013.301410.
Developing an electronic health record (EHR) for methadone treatment recording and decision support.
Xiao L, Cousins G, Courtney B, Hederman L, Fahey T, Dimitrov B
BMC Med Inform Decis Mak. 2011; 11:5.
PMID: 21284849
PMC: 3039554.
DOI: 10.1186/1472-6947-11-5.
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.
Cornish R, Macleod J, Strang J, Vickerman P, Hickman M
BMJ. 2010; 341:c5475.
PMID: 20978062
PMC: 2965139.
DOI: 10.1136/bmj.c5475.